Cardio Diagnostics Holdings Inc
CDIO
NASDAQ
Biotechnology
$2.04
USD
+0.03 (+1.49%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $5.95M
Volume 46.5K
Revenue
$14,450
TTM
-25.9%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-6.47M
TTM
-3.5%
YoY
Operating Cash Flow
$-5.66M
TTM
-2.5%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | -5.0% | -56.6% | -21.2% | +185.1% | -28.3% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.5 | 1.7 | 0.8 | 1.7 | 1.3 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 1.7 | 1.7 | 1.5 | 1.8 | 1.5 |
Operating Income | -1.7 | -1.7 | -1.5 | -1.8 | -1.5 |
EBITDA | -1.6 | -1.6 | -1.4 | -1.7 | -1.4 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
Income Before Income Taxes | -1.7 | -1.7 | -1.5 | -1.8 | -1.5 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -1.7 | -1.7 | -1.5 | -1.8 | -1.5 |
Consolidated Net Income / Loss | -1.7 | -1.7 | -1.5 | -1.8 | -1.5 |
Net Income Attributable to Common Shareholders | -1.7 | -1.7 | -1.5 | -1.8 | -1.5 |
Basic EPS | -$0.97 | -$0.98 | -$0.80 | -$0.63 | -$0.51 |
Diluted EPS | -$0.97 | -$0.98 | -$0.80 | -$0.63 | -$0.51 |
Basic Shares Outstanding | 1.7M | 1.8M | 1.8M | 2.8M | 3.0M |
Diluted Shares Outstanding | 1.7M | 1.8M | 1.8M | 2.8M | 3.0M |